NEWS | May 5, 2015

Dermatologist Jagdeo awarded by American Society for Laser Medicine and Surgery

Jared Jagdeo
Jared Jagdeo

Jared Jagdeo, UC Davis assistant professor of dermatology, has received the 2015 Dr. Horace Furumoto Innovations Young Investigator Award from the American Society for Laser Medicine and Surgery (ASLMS).

Jagdeo, who also has an appointment at the Sacramento VA Medical Center Dermatology Services, received the award at the ASLMS Annual Conference in Kissimmee, Fla., on April 24. He also delivered a presentation, titled “Guiding Light — The Start of a Journey.”

“It is a tremendous honor to receive this award,” said Jagdeo. “I am inspired by Dr. Furumoto’s accomplishments as a translational researcher and share his love of testing news ideas pertaining to lasers, light and energy-based technologies to enhance patient care.”

Jagdeo has received several other awards and honors, including the NIH-UC Davis CTSC K12 Mentored Career Development Award for translational study of light emitting diode-generated visible light for the treatment of skin scarring and fibrotic disease. He also has been awarded for developing new technology and approaches for increasing ablative laser patient safety and optimizing patient-treatment outcomes.

Horace Furumoto was a physicist who pioneered the use of the clinical pulse dye laser to treat port wine stain birthmarks, leading the way for many aesthetic and medical applications and products. As a co-founder of the Candela Laser Corporation, he developed the flashlamp-excited dye laser. He also developed selective photothermolysis, a technology he subsequently used to create devices for treating birthmarks, kidney stones and glaucoma. He died in 2007.

The ASLMS is the world’s largest scientific organization dedicated to promoting research, education and high standards of clinical care in the field of medical laser applications. It provides a forum for the exchange of scientific information and participates in communicating the latest developments in laser medicine and surgery to clinicians, research investigators, government and regulatory agencies, and the public.